20,271 Shares in Acadia Healthcare Company, Inc. $ACHC Acquired by Lido Advisors LLC

Lido Advisors LLC purchased a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 1st quarter, Holdings Channel reports. The firm purchased 20,271 shares of the company’s stock, valued at approximately $474,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Acadia Healthcare during the first quarter worth $1,600,000. Goldman Sachs Group Inc. raised its stake in Acadia Healthcare by 21.1% in the first quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock valued at $21,170,000 after buying an additional 121,444 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Acadia Healthcare by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after buying an additional 27,207 shares during the last quarter. American Century Companies Inc. boosted its position in shares of Acadia Healthcare by 531.5% during the 2nd quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock worth $2,399,000 after acquiring an additional 88,995 shares in the last quarter. Finally, Prudential Financial Inc. boosted its position in shares of Acadia Healthcare by 21.9% during the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock worth $225,000 after acquiring an additional 1,780 shares in the last quarter.

Acadia Healthcare Trading Up 2.9%

NASDAQ:ACHC opened at $28.14 on Friday. The company has a market capitalization of $2.62 billion, a PE ratio of -2.26, a P/E/G ratio of 9.09 and a beta of 0.64. Acadia Healthcare Company, Inc. has a 52-week low of $11.43 and a 52-week high of $35.83. The stock’s 50 day moving average price is $28.10 and its 200 day moving average price is $23.70. The company has a quick ratio of 1.71, a current ratio of 1.57 and a debt-to-equity ratio of 1.20.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.03. The company had revenue of $865.84 million during the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm’s revenue for the quarter was down .4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, research analysts anticipate that Acadia Healthcare Company, Inc. will post 1.51 EPS for the current year.

Wall Street Analysts Forecast Growth

ACHC has been the topic of several research analyst reports. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. UBS Group upped their price target on Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a report on Thursday, July 9th. KeyCorp increased their price target on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Raymond James Financial upgraded shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective for the company in a research report on Monday, May 4th. Finally, Barclays upped their target price on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Acadia Healthcare presently has a consensus rating of “Hold” and an average target price of $29.85.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.